NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference

    BEDMINSTER, N.J., Feb. 29 /CNW/ -- NPS Pharmaceuticals, Inc. (Nasdaq:  
NPSP) announced today that Francois Nader, M.D., executive vice president,
chief operating officer, and chief executive officer-elect is scheduled to
present at the Lehman Brothers Eleventh Annual Global Healthcare Conference in
Miami on Wednesday, March 19, 2008 at 3:15 p.m. ET.  The presentation will be
available as a live webcast with a replay available approximately 24 hours
after the presentation has concluded.  Interested parties may access the
webcast from the NPS website,
    About NPS Pharmaceuticals
    NPS Pharmaceuticals is developing high value specialty therapeutics for
gastrointestinal and endocrine disorders.  The company is currently advancing
two late-stage programs:  GATTEX(TM) (teduglutide) is in Phase 3 clinical
development for intestinal failure associated with short bowel syndrome and
parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical
development as a hormone therapy for hypoparathyroidism.  NPS has also
completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84
[rDNA origin] injection).  NPS complements its internal programs with
strategic partnerships, which include Amgen, GlaxoSmithKline, Kirin, and
Nycomed.  Additional information is available at

For further information:

For further information: Susan Mesco of NPS Pharmaceuticals, Inc., 
+1-908-450-5516 Web Site:

Organization Profile


More on this organization


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890